Brainsgate's Series C Round

Brainsgate raised a round of funding on August 11, 2008.

BrainsGate develops a technology for modulation of cerebro-vascular properties through neuro-stimulation of the spheno-palatine ganglion. Affected properties are central to many CNS disorders - blood …

Articles about Brainsgate's Series C Round: